Copyright
©The Author(s) 2023.
World J Clin Oncol. Apr 24, 2023; 14(4): 138-159
Published online Apr 24, 2023. doi: 10.5306/wjco.v14.i4.138
Published online Apr 24, 2023. doi: 10.5306/wjco.v14.i4.138
Figure 1 Scheme about current glioblastomas treatment strategies and its advantages and limitations.
GBM: Glioblastomas; OS: Overall survival; PFS: Progression-free survival; TMZ: Temozolomide; VEGF: Vascular endothelial growth factor;
- Citation: Rocha Pinheiro SL, Lemos FFB, Marques HS, Silva Luz M, de Oliveira Silva LG, Faria Souza Mendes dos Santos C, da Costa Evangelista K, Calmon MS, Sande Loureiro M, Freire de Melo F. Immunotherapy in glioblastoma treatment: Current state and future prospects. World J Clin Oncol 2023; 14(4): 138-159
- URL: https://www.wjgnet.com/2218-4333/full/v14/i4/138.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i4.138